Perfectly positioned to bridge the gap between R&D and commercial, MA must seize their strategic position within the industry to guide the future of the function.

The regulatory ecosystem of the pharmaceutical industry and people’s decreasing attention spans is proving a complex reality for marketers that has provided an imperative to innovate.

What helps people to stick to their medication regimes, and how can pharma begin to recover their revenue as well as striving for better health outcomes?

A roundtable discussion with two millennial doctors to find out what they want from pharma, both in terms of digital content, rep interactions and more.

Gitte Aabo, President and CEO, LEO Pharma A/S, speaks about LEO’s leading position in dermatology and life-changing moments which help foster the patient-centric environment and mindset that is embedded so deeply within the company.

How can medical affairs teams construct a game plan to make sure they are prepared for the changing landscape within big data?

Amid the digital and data revolution, the rise of social media, and increasing consumer expectations, pharma marketers must up their game to beat competitors.

Dr Ulrich Betz, Vice President of Innovation, Merck KGaA, talks about the evolution of R&D in the pharma space, the use of AI in pharma clinical trial models and fostering a creative team culture.